New medical solutions and the expansion of existing products in several markets drive our growth trajectory in medical dermatology. In addition, our recent acquisitions strengthen our portfolio, positioning us to continue addressing unmet needs. As explained by our Chief Commercial Officer Europe & International, Paolo Cionini, our current treatments have experienced sustained growth and increased sales throughout 2023, as we prepare for forthcoming product launches. With a dedicated team and our focus on our ambition, we are poised to take the lead in the market and enhance the quality of life for countless patients. 📌Check the video below with Lidia Martín and Dirk Menschig to learn more about our business performance and visit our #YearInReview for more information as well as the full video https://lnkd.in/dfbCjQUc #YearInReview #WeAreAlmirall
Great to see you Paolo!
Very inspiring Paolo!
Expert in Healthcare with profound knowledge in the pharmaceutical environment
2dAs always - full speed ahead😎